EAPC Premium Access

The preventive challenge in diabetes & CVD: a multidisciplinary approach.

Event: EuroPrevent 2019
Topic: Diabetes and the Heart
Session type: Satellite Symposium
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education & EPCCS - European Primary Care Cardiovascular Society supported with an educational grant from Novo Nordisk.
Date: 11 April 2019
Time: 12:45 - 13:45

Session

5 presentations in this session

Introduction - The preventive challenge in diabetes & CVD: a multidisciplinary approach.

Speaker: Professor R. Hobbs (Oxford, GB)
Speaker: Assistant Professor M. Hollander (Utrecht, NL)
Thumbnail

The cardiovascular challenge for primary care in diabetes.

Speaker: Professor R. Hobbs (Oxford, GB)
Thumbnail

Type 2 Diabetes & CV outcomes: more than Glucose management? Lessons from GLP1-ra trials.

Speaker: Professor S. Jacob (Villingen, DE)
Thumbnail

Targeting CVD in diabetes: novel strategies to tackle the risk.

Speaker: Professor J. Deanfield (London, GB)
Thumbnail

Panel discussion.

Speaker: Professor R. Hobbs (Oxford, GB)
Speaker: Professor J. Deanfield (London, GB)
Thumbnail

7 speakers from this session

Professor Richard Hobbs

, Oxford (United Kingdom of Great Britain & Northern Ireland)
8 presentations
0 follower

Assistant Professor Monika Hollander

University Medical Center Utrecht, Utrecht (Netherlands (The))
6 presentations
0 follower

Professor Richard Hobbs

, Oxford (United Kingdom of Great Britain & Northern Ireland)
8 presentations
0 follower

Professor Stephan Jacob

, Villingen (Germany)
6 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

Professor Richard Hobbs

, Oxford (United Kingdom of Great Britain & Northern Ireland)
8 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

This platform is supported by

logo Novo Nordisk